Insilico Medicine and Partner Unveil Potent WDR5-MYC Interaction Inhibitors Discovered via Generative AI Platform
In a groundbreaking advancement at the nexus of artificial intelligence and medicinal chemistry, Insilico Medicine, in collaboration with Huadong Medicine ...